Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria

por Zhou, Yanzhao, Yang, Yi, Zhou, Bingyan, Wang, Zhengzheng, Zhu, Ruili, Chen, Xun, Ouyang, Jingzhong, Li, Qingjun, Zhou, Jinxue
Publicado 2021

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis

por Ouyang, Jingzhong, Wang, Zhengzheng, Yuan, Kun, Yang, Yi, Zhou, Yanzhao, Li, Qingjun, Yang, Nanmu, Zhao, Haitao, Zhao, Hong, Zhou, Jinxue
Publicado 2023

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma

por Xu, Ying, Li, Zhuo, Zhou, Yanzhao, Yang, Yi, Ouyang, Jingzhong, Li, Lu, Huang, Zhen, Ye, Feng, Ying, Jianming, Zhao, Hong, Zhou, Jinxue, Zhao, Xinming
Publicado 2023

Gallbladder cancer: current and future treatment options

por Zhou, Yanzhao, Yuan, Kun, Yang, Yi, Ji, Zemin, Zhou, Dezheng, Ouyang, Jingzhong, Wang, Zhengzheng, Wang, Fuqiang, Liu, Chang, Li, Qingjun, Zhang, Qi, Li, Qiang, Shan, Xiao, Zhou, Jinxue
Publicado 2023

A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma

por Xu, Ying, Li, Zhuo, Yang, Yi, Li, Lu, Zhou, Yanzhao, Ouyang, Jingzhong, Huang, Zhen, Wang, Sicong, Xie, Lizhi, Ye, Feng, Zhou, Jinxue, Ying, Jianming, Zhao, Hong, Zhao, Xinming
Publicado 2023